a.westergaard

TL3 Regular · San Sebastián, ES

Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.

Joined 28 September 2024 · last posted 17h · groups: pharmacists

143 posts, newest first. Showing up to 150.

[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #129 · Sourcing › Independent verification · 27 Jul 2026 · 20 likes Post #125 put the caveat in the right place and I want to underline it. Reporting rather than recommending, on Interpreting a result. What happened is above. Whether it…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #126 · Analytics › Home & field testing · 26 Jul 2026 · 15 likes My position on consumer-accessible tests is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
What a certificate commits its issuer to Replied, post #62 · Analytics › COA interpretation · 19 Jul 2026 · 4 likes That is the distinction I keep failing to hold on to. Written down now.
What a reversed-phase purity number actually is Replied, post #54 · Analytics › HPLC & UHPLC · 14 Jul 2026 · 20 likes Right — I had this wrong and I am glad to have read it before it mattered.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #79 · Meta › Announcements · 9 Jul 2026 · 1 like On post #77 — agreed on the reasoning, with one qualification. Whatever the answer on Trust level 3 requirements turns out to be, the method for getting there is the…
System suitability injections: if they failed, the run did not happen — the long version Replied, post #6 · Analytics › HPLC & UHPLC · 8 Jul 2026 · 26 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
Pooling trials with different estimands Replied, post #76 · Evidence › Meta-analyses · 6 Jul 2026 · 0 likes I came in to disagree and I am leaving without a disagreement.
Revisiting: What pooling buys you and what it destroys Replied, post #79 · Evidence › Meta-analyses · 5 Jul 2026 · 18 likes Post #77 describes the usual case. This is about the unusual one. Double extraction with disagreement resolution is standard and is worth checking for, because single…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #90 · Compounds › Semaglutide · 4 Jul 2026 · 25 likes Where I part company with post #86, and it is a narrow parting. On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and…
An appeal that succeeded, with the letter structure Replied, post #12 · Access › Insurance & coverage · 2 Jul 2026 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
Request: a per-category review queue Replied, post #72 · Meta › Feature requests · 1 Jul 2026 · 9 likes Deprecation requests: if you think a feature should be removed or changed, that is also a request. Explain why you think it would improve the site. Reading it back, the…
Pooling trials with different estimands Replied, post #61 · Evidence › Meta-analyses · 30 Jun 2026 · 15 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
Bioimpedance and hydration: why the number moves Replied, post #65 · Outcomes › Body composition · 24 Jun 2026 · 0 likes Post #64 describes the usual case. This is about the unusual one. Photographs under fixed lighting and posture are a genuine record and are the hardest of these to…
How shortages have affected compounding permissions — does this still hold? Replied, post #16 · Access › Shortages · 22 Jun 2026 · 29 likes Shortage status determines what compounding is permitted in some jurisdictions, which links two questions that otherwise seem unrelated. Not disagreeing with anyone…
Insomnia at a dose step: reported experiences — the long version Replied, post #36 · Wellbeing › Sleep · 20 Jun 2026 · 8 likes Insomnia is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #7 · Practice › Side effects · 18 Jun 2026 · 0 likes Two things can be true about Taste changes and food aversion at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the…
Follow-up: Search filters: what is missing Replied, post #129 · Meta › Site feedback · 14 Jun 2026 · 0 likes Coming back to post #125, because the follow-up matters more than the original answer. That would also be the fastest way for a new member to understand what R6…
I have no scientific background — can I still follow the analytics categories? Replied, post #17 · Start Here › Welcome · 10 Jun 2026 · 24 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Publication patterns in the BPC-157 literature, examined Replied, post #11 · Compounds › Repair & healing peptides · 10 Jun 2026 · 0 likes On post #9 — agreed on the reasoning, with one qualification. Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity…
A plateau that disappeared when I changed how I measured — the long version Replied, post #48 · Outcomes › Progress reports · 9 Jun 2026 · 5 likes Include what else changed. Training, illness, travel and a different scale all appear in a series as if they were treatment effects.
A structured critique template this community uses — a second dataset Replied, post #5 · Evidence › Study critique · 7 Jun 2026 · 0 likes The arithmetic in post #2 is right; the assumption feeding it is the part to check. Building consensus on which criticisms matter: if everyone agrees that the sample…
An 18-month record including the parts that went badly Replied, post #34 · Outcomes › Progress reports · 6 Jun 2026 · 5 likes This is the answer, and the reason it is the answer is the more useful part.
Micronutrient adequacy at low total intake Replied, post #7 · Nutrition & Training › Protein & intake · 5 Jun 2026 · 25 likes Answering the question post #4 raises rather than the one it answers. Micronutrition alongside protein: eating protein foods that are also good sources of…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #23 · Practice › Storage & stability · 2 Jun 2026 · 31 likes The version of reconstituted that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and…
I have no scientific background — can I still follow the analytics categories? Replied, post #7 · Start Here › Welcome · 23 May 2026 · 0 likes The category structure looks heavier than it is. There are twenty top-level categories and you will use three of them. Find those three, mute the rest for a month, and…
Run-in periods and the population they select Replied, post #122 · Evidence › Trials · 22 May 2026 · 4 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #16 · Practice › Reconstitution · 18 May 2026 · 2 likes Right, and stated more narrowly than I would have dared to state it.
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #56 · Evidence › Journal club · 14 May 2026 · 32 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
Manufacturer assistance programmes and their eligibility rules Replied, post #25 · Access › Pricing · 12 May 2026 · 10 likes Sensible. I would want the same detail before I acted on it either.
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #37 · Devices › Syringes & needles · 10 May 2026 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
The best-written scientific paper you have read Replied, post #36 · Lounge › Off topic · 8 May 2026 · 31 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page. That is the practical…
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #6 · Nutrition & Training › Protein & intake · 6 May 2026 · 2 likes Where I part company with post #2, and it is a narrow parting. Micronutrient adequacy becomes a real question at very low total intake and is much less discussed than…
The best-written scientific paper you have read Replied, post #29 · Lounge › Off topic · 3 May 2026 · 6 likes The version of best-written scientific paper that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #31 · Practice › Dosing & titration · 2 May 2026 · 0 likes A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An improvised one becomes a series of decisions made on the worst day…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #37 · Analytics › HPLC & UHPLC · 30 Apr 2026 · 6 likes Post #34 put the caveat in the right place and I want to underline it. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase…
Blind submission and why it changes minds — the long version Replied, post #32 · Sourcing › Independent verification · 20 Apr 2026 · 32 likes Narrowing post #30, because the general version has more than one answer. The record shows what was measured. Everything beyond that is inference and this site tries to…
Managing an unplanned gap in supply Replied, post #89 · Access › Shortages · 8 Apr 2026 · 4 likes Post #85 put the caveat in the right place and I want to underline it. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long…
Constipation management, with a dietitian's contribution Replied, post #49 · Practice › Side effects · 6 Apr 2026 · 0 likes Taking post #48 at face value and following it one step further. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not…
Labelling requirements for research chemicals Replied, post #10 · Sourcing › Regulatory · 5 Apr 2026 · 9 likes I think the labelling requirements for research chemicals question is answerable and has not been answered, which is a more optimistic position than most of this thread.
A parcel stationary at a customs facility for nine days Replied, post #42 · Sourcing › Logistics · 26 Mar 2026 · 2 likes Practical answer on parcel stationary, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
Second pass at: Metformin co-administration and additive GI effects Replied, post #69 · Practice › Interactions · 19 Mar 2026 · 0 likes Post #67 is right about the mechanism and I think understates the practical bit. Metformin co-administration would be much easier to settle if anyone reported the…
Coming back to: Time to steady state after a dose increase Replied, post #15 · Pharmacology › Pharmacokinetics · 16 Mar 2026 · 1 like Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #35 · Compounds › Repair & healing peptides · 11 Mar 2026 · 9 likes One more thing on Reading a preclinical wound-healing model that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you…
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #10 · Practice › Administration · 6 Mar 2026 · 10 likes Reading back through, this was answered upthread and I missed it. My fault.
[2026 update] Confounding by indication, explained with a concrete example Replied, post #111 · Evidence › Study critique · 5 Mar 2026 · 1 like A criticism that would apply equally to every trial in the field is worth stating once and is not a reason to discount a particular paper. Happy to be corrected if…
Coming back to: Training through a dose escalation week Replied, post #43 · Nutrition & Training › Resistance training · 4 Mar 2026 · 18 likes Maintenance phases are where most people report training going best, which is unsurprising and is worth saying to anybody struggling during loss.
The lowest dose that does anything: is that a real question? Replied, post #27 · Practice › Dosing & titration · 3 Mar 2026 · 2 likes The starting dose in most of these programmes is a tolerance step and produces little effect by design. Judging the compound at the starting dose is judging the wrong…
The lowest dose that does anything: is that a real question? Replied, post #16 · Practice › Dosing & titration · 2 Mar 2026 · 14 likes Post #15 is right about the mechanism and I think understates the practical bit. Dose equivalence between different incretin analogues is a weak concept. The molecules…
[2026 update] Thyroid function tests during substantial weight change Replied, post #3 · Clinical › Bloodwork · 23 Feb 2026 · 1 like TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
Interpreting a result that disagrees with the supplier's certificate Replied, post #126 · Sourcing › Independent verification · 17 Feb 2026 · 22 likes My experience of interpreting a result contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is…
Second pass at: Identical chromatograms across two different lots Replied, post #11 · Sourcing › Red flags · 16 Feb 2026 · 19 likes Careful with the language on Identical chromatograms. "Not detected" and "not present" are different findings and the first is a statement about the method.
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #37 · Evidence › Trials · 14 Feb 2026 · 22 likes Coming back to post #33, because the follow-up matters more than the original answer. The most useful thing anyone has posted about Reading a supplementary appendix in…
Sample size intuition for a personal experiment — does this still hold? Started this topic · Research Methods › Statistics · 3 Feb 2026 · 15 likes Sample size intuition for a personal experiment — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below.…
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #30 · Practice › Side effects · 2 Feb 2026 · 18 likes Having read the whole nausea timeline thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #3 · Compounds › Tirzepatide · 29 Jan 2026 · 7 likes Where I part company with the opening post, and it is a narrow parting. My experience of 2.5 mg starting dose contradicts the reply above. I am posting it as a data…
Tracking that stops updating and then resumes — the long version Replied, post #70 · Sourcing › Logistics · 24 Jan 2026 · 13 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. If the premise is wrong,…
Adsorption to container surfaces and to plastics Replied, post #7 · Pharmacology › Formulation chemistry · 16 Jan 2026 · 2 likes Reading back through the adsorption threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That seems…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #100 · Practice › Side effects · 14 Jan 2026 · 30 likes I read post #96 twice before replying, because I had assumed the opposite. The published rates come from populations that were titrated on a defined schedule with…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #109 · Analytics › COA interpretation · 12 Jan 2026 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Liver enzymes drifting down and what that usually means Replied, post #41 · Clinical › Bloodwork · 29 Dec 2025 · 32 likes Worth separating two things that post #38 runs together. Where a panel includes a calculated value, that value inherits the imprecision of everything it was calculated…
Vomiting: when it is expected and when it is a reason to stop Replied, post #18 · Practice › Side effects · 26 Dec 2025 · 17 likes This follows post #17 rather than contradicting it. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #3 · Research Methods › Statistics · 26 Dec 2025 · 0 likes Regression to the mean: if you select people with extreme values (very high or very low), their next measurement is often less extreme just by chance. This can look…
Coming back to: Washout: how long is long enough, and for what purpose Started this topic · Pharmacology › Pharmacokinetics · 21 Dec 2025 · 51 likes Posting this under the heading it deserves: Washout: how long is long enough, and for what purpose Everything below is what sits behind that. A narrow question about…
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #3 · Regional › UK & Ireland · 20 Dec 2025 · 8 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #4 · Data & Tools › Calculators · 15 Dec 2025 · 6 likes Rounding behaviour is where two tools disagree. One rounding to the nearest graduation and one to two decimal places will produce different advice from identical inputs.
[2026 update] Whether protein timing matters at a large deficit Replied, post #4 · Nutrition & Training › Protein & intake · 13 Dec 2025 · 0 likes Narrowing post #3, because the general version has more than one answer. Density matters more than quantity when total intake is limited. The same protein in a smaller…
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #14 · Compounds › Semaglutide · 6 Dec 2025 · 0 likes Post #11 is right about the mechanism and I think understates the practical bit. The SELECT trial changed the positioning because it was the first cardiovascular…
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #8 · Compounds › Oral incretins · 1 Dec 2025 · 12 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
EMA product information as a primary source Replied, post #73 · Regional › European Union · 16 Nov 2025 · 0 likes EMA product information is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone…
Second pass at: Programming during a large energy deficit Replied, post #74 · Nutrition & Training › Resistance training · 9 Nov 2025 · 13 likes A methods point on Programming during a large energy rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the…
Revisiting: Is there a ceiling dose beyond which semaglutide stops adding benefit? Started this topic · Compounds › Semaglutide · 9 Nov 2025 · 16 likes Revisiting: Is there a ceiling dose beyond which semaglutide stops adding benefit? — that is the question, and I have not found it answered plainly anywhere I have…
Reading an interaction checker output critically Replied, post #29 · Practice › Interactions · 25 Oct 2025 · 1 like Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
Reading SURMOUNT-1 without the press release Replied, post #40 · Compounds › Tirzepatide · 21 Oct 2025 · 1 like Confirming post #39 from a second method, which matters more than confirming it from a second person. The most useful thing anyone has posted about reading SURMOUNT-1…
Pooling trials with different estimands — what changed since Replied, post #36 · Evidence › Meta-analyses · 12 Oct 2025 · 0 likes Worth stating the null on Pooling trials with different estimands before we explain it: the observation may be nothing. That possibility deserves a sentence and usually…
About the Feature requests category Replied, post #4 · Meta › Feature requests · 2 Oct 2025 · 7 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #14 · Compounds › Cagrilintide & amylin analogues · 1 Oct 2025 · 6 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
A preprint whose numbers changed substantially at publication Replied, post #72 · Evidence › Preprints · 30 Sep 2025 · 31 likes Retractions and corrections do not propagate well from preprint servers. A citation that was fine when made can quietly become wrong. Genuinely open to being wrong…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #100 · Practice › Side effects · 28 Sep 2025 · 6 likes That matches what I have seen, for whatever a single anecdote is worth.
Revisiting: Why I ask for the gradient before I discuss the number Replied, post #20 · Analytics › HPLC & UHPLC · 28 Sep 2025 · 0 likes Adding the measurement that post #17 says would settle it. This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #98 · Evidence › Study critique · 15 Sep 2025 · 5 likes Everything in post #96 holds. The case it does not cover is the one I have. I would rather this thread reach "we do not know" about Reverse causation than reach a…
AOD-9604 and the fragment hypothesis, revisited Replied, post #13 · Compounds › Other compounds · 7 Sep 2025 · 2 likes I would rather this thread reach "we do not know" about AOD-9604 than reach a confident answer that nobody can support when asked.
Vagal afferents and the gut-brain pathway — one year on Replied, post #3 · Pharmacology › Receptor biology · 3 Sep 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Species differences in receptor pharmacology are substantial in this family, which is one reason…
When a preprint is the best available evidence and we say so Replied, post #129 · Evidence › Preprints · 2 Sep 2025 · 26 likes Worth separating preprint as a question about the compound from preprint as a question about the documentation. They get answered by different people and only one of…
Request: a diff view for wiki revisions — the long version Replied, post #33 · Meta › Feature requests · 22 Aug 2025 · 6 likes What I want from this diff view for wiki revisions thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can…
When a preprint is the best available evidence and we say so Replied, post #79 · Evidence › Preprints · 20 Aug 2025 · 14 likes I had written a reply contradicting post #75 and deleted it. Here is what survived. Where numbers change between preprint and published version, the changes are not…
How to research a compound with no human data without deceiving yourself Replied, post #112 · Compounds › Other compounds · 4 Aug 2025 · 0 likes That reframing is the whole thing. The facts I already had.
Antibiotics and a course of something with delayed emptying Replied, post #107 · Practice › Interactions · 2 Aug 2025 · 2 likes Speaking only to antibiotics as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
Substitution between formats during a shortage Replied, post #32 · Access › Shortages · 2 Aug 2025 · 17 likes That is a cleaner way of putting what I was circling around.
Hepatic impairment and the absence of data Replied, post #4 · Clinical › Special populations · 30 Jul 2025 · 28 likes Building on post #2 rather than restating it. A clinician's reasoning in this situation typically weighs mechanism, related-population data and the consequences of…
Pooling trials with different estimands — what changed since Replied, post #5 · Evidence › Meta-analyses · 20 Jul 2025 · 6 likes For anyone finding this later: the short answer on Pooling trials with different estimands is that it depends on one thing, and the rest of the thread is people…
A field-by-field walk through a certificate of analysis Replied, post #51 · Analytics › COA interpretation · 15 Jul 2025 · 30 likes Where I part company with post #49, and it is a narrow parting. The number people quote for field-by-field walk through a certificate is a central estimate presented…
Why "any advice?" is the least effective ending for a post — the long version Replied, post #22 · Start Here › How to Ask · 8 Jul 2025 · 1 like Say what you have already ruled out. "It is not the diluent because I tried a second vial from a different box" saves three replies suggesting the diluent. Noting that…
Specification in the result column: why that is a meaningful error Replied, post #16 · Analytics › COA interpretation · 7 Jul 2025 · 9 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #15 · Compounds › Retatrutide · 5 Jul 2025 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #44 · Evidence › Trials · 21 Jun 2025 · 17 likes Answering the question post #41 raises rather than the one it answers. What I would tell a new member reading about Sample size calculations for the first time: the…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #101 · Compounds › Cagrilintide & amylin analogues · 15 Jun 2025 · 0 likes Marking my place. If it changes for me I will come back and say so.
Half-life, steady state, and accumulation worked through Replied, post #115 · Pharmacology › Pharmacokinetics · 14 Jun 2025 · 29 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
Substitution between formats during a shortage Replied, post #9 · Access › Shortages · 13 Jun 2025 · 1 like Switching presentation or strength during a shortage is a prescribing decision rather than a substitution anybody should improvise.
Hepatic steatosis: what the MASH trial evidence supports Replied, post #64 · Clinical › Comorbidities · 13 Jun 2025 · 13 likes Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist. I would want to see it…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #31 · Nutrition & Training › Protein & intake · 6 Jun 2025 · 13 likes Confirming post #28 from a second method, which matters more than confirming it from a second person. Fibre: adequate fibre intake supports fullness and gut motility,…
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #8 · Compounds › Semaglutide · 27 May 2025 · 30 likes Post #5 is right about the mechanism and I think understates the practical bit. Renal outcomes moved this compound out of the metabolic-only conversation. FLOW reported…
DXA precision and the least significant change for lean mass — the long version Replied, post #104 · Outcomes › Body composition · 27 May 2025 · 30 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure. I…
Reading a chromatogram someone posted without axes Replied, post #32 · Analytics › HPLC & UHPLC · 13 May 2025 · 20 likes What would change my mind on reading a chromatogram is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather…
Follow-up: How much fluid is actually needed, and how you would know Replied, post #13 · Nutrition & Training › Hydration & electrolytes · 13 May 2025 · 21 likes Adding salt to food is the intervention most consistently reported as helping and is also the one least likely to cause harm.
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #32 · Sourcing › Independent verification · 4 May 2025 · 0 likes Post #28 describes the usual case. This is about the unusual one. The lot identifier has to match across vial, certificate and invoice for any of this to mean anything.…
Adducts: sodium, potassium, and the peak you did not expect Replied, post #78 · Analytics › Mass spectrometry · 24 Apr 2025 · 2 likes Post #74 describes the usual case. This is about the unusual one. The honest answer on adducts is that it depends, and the useful part is the list of what it depends…
A well-designed study with a badly written abstract Replied, post #39 · Evidence › Study critique · 23 Apr 2025 · 7 likes The question underneath well-designed study is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you…
Individual participant data versus aggregate data Replied, post #27 · Evidence › Meta-analyses · 17 Apr 2025 · 16 likes Picking up post #26: that is the part I would want checked first. I would rather this thread reach "we do not know" about individual participant data versus aggregate…
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #23 · Meta › Wiki maintenance · 17 Apr 2025 · 25 likes Citation sweep results sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #2 · Evidence › Journal club · 16 Apr 2025 · 3 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
Retatrutide dose escalation in the published trials Replied, post #107 · Compounds › Retatrutide · 9 Apr 2025 · 0 likes On retatrutide dose escalation the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #47 · Clinical › Comorbidities · 1 Apr 2025 · 14 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #65 · Evidence › Journal club · 30 Mar 2025 · 0 likes The thing about SUSTAIN 6 that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
Why cagrilintide alone is discussed so much less than in combination Replied, post #60 · Compounds › Cagrilintide & amylin analogues · 29 Mar 2025 · 5 likes The reason cagrilintide alone keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #3 · Evidence › Journal club · 18 Mar 2025 · 7 likes A definition problem is doing most of the work in this STEP 4 discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is…
A promotion I argued against, and why I lost Replied, post #133 · Documentation › Doc review · 14 Mar 2025 · 0 likes Narrowing post #130, because the general version has more than one answer. The arithmetic on promotion is the easy part and it is where the errors are, which is an…
A promotion I argued against, and why I lost Replied, post #124 · Documentation › Doc review · 8 Mar 2025 · 8 likes The practical version of promotion is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
Adducts: sodium, potassium, and the peak you did not expect Replied, post #27 · Analytics › Mass spectrometry · 6 Mar 2025 · 0 likes I had written a reply contradicting post #25 and deleted it. Here is what survived. I have three months of notes on adducts and the honest summary is that the trend is…
Adjudicated events and why the definition matters — the long version Replied, post #20 · Evidence › Trials · 22 Feb 2025 · 28 likes Worth separating two things that post #16 runs together. Small methodological point on Adjudicated events: repeating a measurement is cheap and resolves most of what is…
Pancreatitis history and the risk calculus — a second dataset Replied, post #24 · Safety › Contraindications · 19 Feb 2025 · 11 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
Coming back to: Official shortage notices and what they authorise Replied, post #15 · Access › Shortages · 13 Feb 2025 · 0 likes Stockpiling in response to a shortage worsens it, which is true and is a poor argument to make to somebody who has run out.
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #34 · Clinical › Bloodwork · 28 Jan 2025 · 29 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason.
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #32 · Evidence › Journal club · 26 Jan 2025 · 11 likes On SUSTAIN 6: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #125 · Compounds › Tirzepatide · 2 Jan 2025 · 1 like Narrowing post #122, because the general version has more than one answer. The five maintenance doses in the tirzepatide programme give a genuine dose-response curve,…
Fixed versus detachable needles: the trade-offs Replied, post #71 · Devices › Syringes & needles · 25 Dec 2024 · 8 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
What a seizure notice actually says Replied, post #17 · Sourcing › Logistics · 20 Dec 2024 · 0 likes Post #15 answers the question as asked. The question underneath it is different. Split shipments reduce single-point risk and increase the number of transits. Which…
When "no data" is the complete and final answer Replied, post #44 · Compounds › Other compounds · 18 Dec 2024 · 9 likes The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand accounts. Saying so is more useful than assembling the accounts into…
When "no data" is the complete and final answer Replied, post #35 · Compounds › Other compounds · 5 Dec 2024 · 23 likes A compound with no established assay is a compound where a certificate can say almost anything. That is not an accusation about anyone; it is a statement about what a…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #32 · Compounds › Other compounds · 3 Dec 2024 · 0 likes Second this, and I would have said it less carefully.
Time to steady state after a dose increase Replied, post #119 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 5 likes The arithmetic in post #118 is right; the assumption feeding it is the part to check. Renal clearance: these compounds are cleared partly via the kidney. In severe…
Follow-up: Recovery when intake is low: what to cut first Replied, post #7 · Nutrition & Training › Resistance training · 4 Nov 2024 · 0 likes Cardiovascular work has its own benefits and is not a substitute for a resistance stimulus for this particular purpose. It is the sort of thing that seems obvious in…
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #54 · Wellbeing › Mental health · 27 Oct 2024 · 0 likes Everything in post #50 holds. The case it does not cover is the one I have. I keep a log for Food noise specifically because my memory of it turned out to be…
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #21 · Practice › Side effects · 19 Oct 2024 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
The topic list is dense — is that deliberate? Replied, post #39 · Meta › Site feedback · 16 Oct 2024 · 15 likes My position on topic list is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #58 · Evidence › Journal club · 29 Sep 2024 · 9 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
People with a low starting BMI: where the evidence stops Replied, post #4 · Clinical › Special populations · 27 Sep 2024 · 11 likes Post-surgical populations, particularly after procedures affecting the gastrointestinal tract, interact with a delayed-emptying mechanism in ways that need specialist…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #35 · Clinical › Bloodwork · 17 Sep 2024 · 16 likes What I would check first on bring a laboratory is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
Over-dilution: when your dose falls below one readable graduation Replied, post #3 · Practice › Reconstitution · 1 Sep 2024 · 10 likes Confirming post #2 from a second method, which matters more than confirming it from a second person. Worked example, since the arithmetic is the whole question. Five…
Correlation in a self-tracked dataset: what it can support Replied, post #98 · Research Methods › Statistics · 24 Aug 2024 · 0 likes Coming back to post #94, because the follow-up matters more than the original answer. Percentages of small denominators should be reported with the denominator. Two out…
Correlation in a self-tracked dataset: what it can support Replied, post #73 · Research Methods › Statistics · 23 Aug 2024 · 4 likes One caution on correlation: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
Coming back to: Purity assay versus content assay: two different numbers Replied, post #34 · Analytics › COA interpretation · 10 Aug 2024 · 0 likes Worth separating two things that post #32 runs together. Purity and content are different measurements: purity tells you what proportion of the detected material is the…
Journal club: FLOW and the renal composite, component by component Replied, post #5 · Evidence › Journal club · 8 Jul 2024 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Assessing a warm arrival: the decision process — one year on Replied, post #73 · Sourcing › Logistics · 31 May 2024 · 24 likes Marking my uncertainty on Assessing a warm arrival explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…